American Glaucoma Society
AGS Abstracts

AGS Map About AGS Become a Member Locate a Member Near YouLinks to Resources AGS Abstracts Contact AGS AGS Home  

2003 AGS Annual Meeting

March 6-9, 2003
San Francisco, California


Search 2003 Scientific Abstracts and Posters  



  1. Evaluation Of Two Families With Autosomal Dominant Normal Tension Glaucoma For Mutations In The Optineurin Gene
    Wallace L. M. Alward
  2. Pigmentary Glaucoma: One Gene or Two
    Paul R. Lichter
  3. The Effects of Mechanical Stress on Nuclear Factor kappa B Activation in Trabecular Meshwork Cells
    Darrell WuDunn
  4. New Evidence of Pulsatile Aqueous Discharge into Schlemm’s Canal, from Schlemm’s Canal into Collector Channel Ostia, and from Aqueous Veins Into Episcleral Veins
    Murray A. Johnstone
  5. Aqueous Humor Dynamics in Pigment Dispersion Syndrome
    Carol B. Toris
  6. Glaucoma Prevalence in the United States: Results of a Meta-Analysis
    David S. Friedman
  7. Glaucoma as a Cause of Blindness in the United States
    Nathan G. Congdon
  8. Family Similarity of Measurements of Optic Discs and Cups and Intraocular Pressure. Beaver Dam Eye Study
    Barbara E.K. Klein
  9. Pseudoexfoliation Syndrome: A Population-Based Study
    Margaret P. Good
  10. Effect of Race and Gender on Central Corneal Thickness (CCT) in Glaucoma and Glaucoma Suspect Patients
    Karanjit S. Kooner
  11. Anterior Laminar Capillary Patency is Markedly Diminished within Serial Sagittal Sections of Normal and Early Glaucoma Monkey Eyes Perfusion Fixed at High IOP
    Claude F. Burgoyne
  12. Optical Coherence Tomography Findings Predicting Future Visual Field Progression
    Gadi Wollstein
  13. Retinal Nerve Fiber Layer Measurements Are Not Changed Following Laser In-Situ Keratomileusis (LASIK) For High Myopia As Measured By Scanning Laser Polarimetry With Custom Compensation For Anterior Segment Birefringence
    Neil T. Choplin
  14. Evaluation of OCT 3 Border Detection Algorithms
    Hiroshi Ishikawa
  15. Helicobacter Pylori Infection and the Risk for Open Angle Glaucoma
    Frederick S. Mikelberg
  16. Quality of Life in Glaucoma Patients Using the Patient Generated Index (PGI)
    George L. Spaeth
  17. Dynamic Contour Tonometry-A Comparative Study on Human Cadaver Eyes
    Christoph Kniestedt
  18. Evaluating Glaucomatous Visual Field Deterioration with Time Series Analysis
    Mark C. Westcott
  19. A New Visual Field Staging System for Glaucoma: Observer Agreement Compared to Three Other Systems
    Jeffrey D. Henderer
  20. Retinal Ganglion Cell Protection with Geranylgeranylacetone, A Heat Shock Protein Inducer in a Rat Glaucoma Model
    Joseph Caprioli
  21. Comparison Of Long-term Outcome Between SLT and ALT in Chronic Open-Angle Glaucoma Patients
    Mark S. Juzych
  22. Practice Preferences of American Glaucoma Society Members Regarding the Use of Antifibrosis Agents and Glaucoma Drainage Devices
    Richard K. Parrish, II
  23. Long-Term Success Rate of Primary Glaucoma Triple Procedure Study With Subconjunctival Versus Subscleral Application of Mitomycin C (MMC) Versus No Adjunctive MMC
    Vikas Chopra
  24. Novel Glaucoma Surgical Treatment-Goniectomy with Histology
    George S. Baerveldt
  25. Mitomycin-C Augmented Deep Sclerectomy with Collagen Wick Implantation for High-Risk Glaucoma
    Iqbal Ike K. Ahmed
  26. Needle Revision of Failed Filtering Blebs using 5- Fluorouracil and a Combined Ab-Externo and Ab-Interno Approach
    James J. Pasternack


  1. Development of Evidence-Based Treatment Recommendations for the Medical Management of Glaucoma. Initial Findings: Definitions of Disease States and Goals of Therapy

  2. Anne L.Coleman

  3. A Comparison Of Latanoprost, Bimatoprost, And Travoprost In Patients With Elevated Intraocular Pressure: A 12-Week, Masked-Evaluator, Multicenter Study

  4. Richard Parrish

  5. Comparison of IOP-Lowering Efficacy of Bimatoprost

  6. Monte Dirks

  7. Stability of Latanoprost in a Community Setting

  8. Rohit Varma

  9. Patient Persistency With Topical Prostaglandin Therapy In The Management Of Glaucoma

  10. Gail F. Schwartz

  11. A Diurnal Evaluation of IOP in Patients Treated With Travatan® or Xalatan®

  12. Harvey DuBiner

  13. Efficacy of Bimatoprost 0.03% in Glaucoma or Ocular Hypertension Patients Non- Responsive to Latanoprost 0.005%

  14. Robert Williams

  15. Clinical and Economic Outcomes Of Latanoprost, Bimatoprost, Or Travoprost Therapy In Glaucoma Patients: A Three-month Retrospective Study

  16. Gail F. Schwartz

  17. Comparing Bimatoprost To Timolol In Patients With Glaucoma Or Ocular Hypertension: Results After Two Years

  18. John Cohen

  19. Ocular Hypotensive Efficacy of Bimatoprost 0.03% and Travoprost 0.004% in Patients with Glaucoma or Ocular Hypertension

  20. Louis Cantor

  21. Efficacy and Safety of Changing to Latanoprost 0.005% From Other Monotherapy Treatment

  22. Thom Zimmerman

  23. Frequency of Adjunctive Medication Use Associated with Travoprost, Bimatoprost and Latanoprost Therapy

  24. Alan Robin and Trong Le

  25. Hyperemia And Myalgia: A 28 Day Prospective Double-Masked Comparison Of Travoprost And Bimatoprost Therapy in Primary Open Angle Glaucoma And Ocular Hypertension

  26. Alan Robin

  27. An Evaluation of IOP Changes in Patients Switched From Brimonidine Monotherapy to Travoprost® Monotherapy in the S.T.A.R.T. Trial

  28. Martin Kaback

  29. An Analysis of Patients Switched From Latanoprost and One Adjunctive Medication Therapy to Travatan® Monotherapy in the S.T.A.R.T. Trial

  30. Paul Schacknow

  31. Optimization of Plastic Materials for Travatan® Containers

  32. Howard Barnebey

  33. An Evaluation of the Comfort of Alphagan® P Compared with Alphagan® in Irritated Eyes

  34. Thomas K. Mundorf

  35. Comparison of Inflammatory Cell Infiltration in the Conjunctiva of Patients Using Chronic Topical Glaucoma Medications

  36. Robert Noecker

  37. Comparison of Alphagan vs Alphagan P on Rabbit Corneal Epithelium

  38. Robert Noecker

  39. A double-masked, randomized, parallel study of the safety and efficacy of Timolol LA in patients with ocular hypertension or open-angle glaucoma

  40. Thomas K. Mundorf

  41. Primary Open Angle Glaucoma With Heterogenous Onset is Linked to Chromosome 2 in a Peruvian Family

  42. Rodolfo A. Perez-Grossmann

  43. The Rate of Disease Progression is Accelerated by the TIGR/MYOC Mt.1 Variant in POAG Patients: Independent Analyses of Effects on Optic Disc and Visual Field Measures of Damage

  44. J.R. Polansky

  45. A Model To Help Evaluate The Cost Of Glaucoma Screening

  46. Alan L. Robin

  47. Does Community Visual Field Screening Encourage Participants to Have Eye Exams?

  48. Steven L. Mansberger

  49. A Novel Way of Estimating the Course of Glaucoma

  50. George L. Spaeth

  51. Optic Nerve Evaluation – Pilot Study with Specialists and General Ophthalmologists

  52. Paul Lee

  53. The Effect of Pupillary Dilation on Retinal Nerve Fiber Layer Thickness Measurements Using Optical Coherence Tomography (OCT-3)

  54. Samiah Zafar

  55. A Cross-sectional Analysis Of The Blue Arc Entoptic Phenomenon In A Clinic- based Population

  56. Louis Pasquale

  57. Evaluation of the Accuracy of the Proview Intraocular Pressure Monitor Compared to Applanation Tonometry

  58. Ramesh Ayyala

  59. Comparison of Pre-operative and Post-operative IOP measurements in Lasik Patients using the Proview Eye Pressure Monitor and a Goldmann Applanation Tonometer

  60. Anjali Hawkins

  61. Retro-Iridial Lines of Vogt and Pigment Dispersion

  62. Sayoko E. Moroi

  63. Selective Laser Trabeculoplasty Significantly Decreases Intraocular Pressure and Reduces Medication Use

  64. Sean Thomas

  65. Short-Term Intraocular Pressure Results of a Modified Viscocanalostomy

  66. Bruce Cameron

  67. Short-Term Intraocular Pressure Results of a Modified Viscocanalostomy Combined with Cataract Extraction

  68. Bruce Cameron

  69. Histopathologic Correlation of Viscocanalostomy Dissection

  70. Thomas W Samuelson

  71. The Hypertensive Phase after Glaucoma Drainage Implant Surgery

  72. Kouros Nouri-Mahdavi

  73. Optic Nerve Changes Following Posterior Insertion of Glaucoma Drainage Device in a Rabbit Model

  74. Ramesh Ayyala

  75. Risk Of Aqueous Misdirection In Phacoemulsification Post-Acute Angle Closure Glaucoma

  76. Christoph Kranemann

  77. Plateau Iris & Phacoemulsification – Surprising UBM Findings

  78. Christoph Kranemann

  79. Ophthalmologist and pharmaceutical personnel knowledge of new PhRMA marketing code

  80. Jonathan Myers

::: top of page ::: abstracts 2003 ::: abstracts ::: home :::